Chen K - Search Results

1

Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines 2022, 10, 130.

Chen K, Si Y, Guan JS, Zhou Z, Kim S, Kim T, Shan L, Willey CD, Zhou L, Liu X. Chen K, et al. Biomedicines. 2023 Dec 29;12(1):86. doi: 10.3390/biomedicines12010086. Biomedicines. 2023. PMID: 38255327 Free PMC article.

2

Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy.

Si Y, Kim S, Ou J, Lu Y, Ernst P, Chen K, Whitt J, Carter AM, Markert JM, Bibb JA, Chen H, Zhou L, Jaskula-Sztul R, Liu XM. Si Y, et al. Among authors: chen k, chen h. Cancer Gene Ther. 2021 Aug;28(7-8):799-812. doi: 10.1038/s41417-020-0196-5. Epub 2020 Jul 20. Cancer Gene Ther. 2021. PMID: 32684623 Free PMC article.

3

Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment.

Si Y, Guan J, Xu Y, Chen K, Kim S, Zhou L, Jaskula-Sztul R, Liu XM. Si Y, et al. Among authors: chen k. Pharmaceutics. 2020 Nov 11;12(11):1079. doi: 10.3390/pharmaceutics12111079. Pharmaceutics. 2020. PMID: 33187322 Free PMC article.

4

Anti-EGFR antibody-drug conjugate for triple-negative breast cancer therapy.

Si Y, Xu Y, Guan J, Chen K, Kim S, Yang ES, Zhou L, Liu XM. Si Y, et al. Among authors: chen k. Eng Life Sci. 2020 Oct 7;21(1-2):37-44. doi: 10.1002/elsc.202000027. eCollection 2021 Jan. Eng Life Sci. 2020. PMID: 33531889 Free PMC article.

5

Investigation into the difference in mitochondrial-cytosolic calcium coupling between adult cardiomyocyte and hiPSC-CM using a novel multifunctional genetic probe.

Ernst P, Chen K, Tang Y, Kim S, Guan J, He J, Xie M, Zhang JJ, Liu XM, Zhou L. Ernst P, et al. Among authors: chen k. Pflugers Arch. 2021 Mar;473(3):447-459. doi: 10.1007/s00424-021-02524-3. Epub 2021 Feb 15. Pflugers Arch. 2021. PMID: 33587181 Free PMC article.

6

Antibody-Drug Conjugate to Treat Meningiomas.

Chen K, Si Y, Ou J, Guan JS, Kim S, Ernst P, Zhang Y, Zhou L, Han X, Liu XM. Chen K, et al. Pharmaceuticals (Basel). 2021 May 2;14(5):427. doi: 10.3390/ph14050427. Pharmaceuticals (Basel). 2021. PMID: 34063284 Free PMC article.

7

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer.

Si Y, Zhang Y, Ngo HG, Guan JS, Chen K, Wang Q, Singh AP, Xu Y, Zhou L, Yang ES, Liu XM. Si Y, et al. Among authors: chen k. Cancers (Basel). 2021 Jul 26;13(15):3749. doi: 10.3390/cancers13153749. Cancers (Basel). 2021. PMID: 34359650 Free PMC article.

8

Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers.

Si Y, Zhang Y, Guan JS, Ngo HG, Totoro A, Singh AP, Chen K, Xu Y, Yang ES, Zhou L, Liu R, Liu XM. Si Y, et al. Among authors: chen k. Vaccines (Basel). 2021 Aug 10;9(8):882. doi: 10.3390/vaccines9080882. Vaccines (Basel). 2021. PMID: 34452008 Free PMC article.

9

Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma.

Chen K, Si Y, Guan JS, Zhou Z, Kim S, Kim T, Shan L, Willey CD, Zhou L, Liu X. Chen K, et al. Biomedicines. 2022 Jan 7;10(1):130. doi: 10.3390/biomedicines10010130. Biomedicines. 2022. PMID: 35052809 Free PMC article.

10

Targeted EV to Deliver Chemotherapy to Treat Triple-Negative Breast Cancers.

Si Y, Chen K, Ngo HG, Guan JS, Totoro A, Zhou Z, Kim S, Kim T, Zhou L, Liu X. Si Y, et al. Among authors: chen k. Pharmaceutics. 2022 Jan 7;14(1):146. doi: 10.3390/pharmaceutics14010146. Pharmaceutics. 2022. PMID: 35057042 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28,305 results

Search Page